Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Graves Orbitopathy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01798966
What this trial is testing

Twenty-four Hour Intraocular Pressure Patterns in Patients With Uncontrolled Thyroid Eye Disease

Who this might be right for
Thyroid Eye Disease
Sensimed AG 10
Large-scale testing (Phase 3)Looking for participantsNCT03131726
What this trial is testing

Treatment of Graves´ophthalmopathy with Simvastatin (GO-S)

Who this might be right for
Graves OphthalmopathyThyroid Associated OphthalmopathyThyroid Associated Orbitopathy
Lund University 80
Not applicableUnknownNCT05199103
What this trial is testing

Antithymocyte Globulin as a Second Line Therapy in Graves Orbitopathy

Who this might be right for
Graves Orbitopathy
Medical University of Silesia 20
Not applicableLooking for participantsNCT06275373
What this trial is testing

The Effect of Teprotumumab on Thyroid Eye Disease and Thyroid Dysfunction

Who this might be right for
Thyroid Eye DiseaseGraves OphthalmopathyGraves Disease
Walter Reed National Military Medical Center 100
Large-scale testing (Phase 3)UnknownNCT03066076
What this trial is testing

Total Thyroidectomy Versus Thionamides in Patients With Moderate-to-Severe Graves' Ophthalmopathy

Who this might be right for
Graves DiseaseGraves OphthalmopathyGraves' Ophthalmopathy Worsened
Medical University of Vienna 60
Large-scale testing (Phase 3)Active Not RecruitingNCT06812325
What this trial is testing

A Safety and Tolerability Study of VRDN-003 in Participants With Thyroid Eye Disease (TED)

Who this might be right for
Thyroid Eye Disease (TED)
Viridian Therapeutics, Inc. 320
Large-scale testing (Phase 3)UnknownNCT05015127
What this trial is testing

Evaluate the Efficacy and Safety of HBM9161 on Moderate to Severe Thyroid Eye Disease

Who this might be right for
Thyroid Ophthalmopathy
Harbour BioMed (Guangzhou) Co. Ltd. 36
Not applicableUnknownNCT04704414
What this trial is testing

Exophthalmometry With 3D Face Scanners

Who this might be right for
ExophthalmosGraves OphthalmopathyOrbital Tumor+1 more
University of Zurich 180
Testing effectiveness (Phase 2)Ended earlyNCT02845336
What this trial is testing

Celecoxib for Thyroid Eye Disease

Who this might be right for
Thyroid Eye Disease
Johns Hopkins University 7
Not applicableStudy completedNCT07085117
What this trial is testing

Real World Study to Describe the Effectiveness and Safety of Teprotumumab Among Thyroid Eye Disease Patients

Who this might be right for
Thyroid Eye Disease
Amgen 5
Post-approval studies (Phase 4)Study completedNCT03667157
What this trial is testing

Liver Function After Intravenous Methylprednisolone Administration

Who this might be right for
Graves DiseaseGraves OphthalmopathyLiver Diseases+11 more
Medical University of Warsaw 68
Large-scale testing (Phase 3)Ended earlyNCT04737330
What this trial is testing

The Efficacy and Safety of Secukinumab 300 mg in Patients With Thyroid Eye Disease (TED)

Who this might be right for
Thyroid Eye DiseaseGraves Orbitopathy
Novartis Pharmaceuticals 28
Not applicableEnded earlyNCT05678374
What this trial is testing

Exploring Immunological Markers Associated With Mental Fatigue in Graves' Disease

Who this might be right for
Graves DiseaseGraves OphthalmopathyMental Fatigue+2 more
Vastra Gotaland Region 94
Testing effectiveness (Phase 2)Study completedNCT05683496
What this trial is testing

Efficacy and Safety of Lonigutamab in Subjects With Thyroid Eye Disease (TED)

Who this might be right for
Thyroid Eye Disease
ACELYRIN Inc. 31
Large-scale testing (Phase 3)Active Not RecruitingNCT06625398
What this trial is testing

An Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants With Chronic Thyroid Eye Disease (TED)

Who this might be right for
Thyroid Eye Disease
Viridian Therapeutics, Inc. 204
Not applicableStudy completedNCT06585592
What this trial is testing

Establishment of Multimodal-multiparametric Progressive Prediction Models for Thyroid Associated Ophthalmopathy

Who this might be right for
Thyroid-Associated Ophthalmopathy
Shanghai Changzheng Hospital 500
Testing effectiveness (Phase 2)Study completedNCT00424151
What this trial is testing

Rituximab Treatment of Graves' Dysthyroid Ophthalmopathy

Who this might be right for
Graves' Dysthyroid OphthalmopathyThyroid Related Orbitopathy
Silkiss, Rona Z., M.D., FACS 12
Not applicableStudy completedNCT02693808
What this trial is testing

New Treatment for Patients With Temporal Hollowing After Lateral Wall Decompression

Who this might be right for
Thyroid-Associated Ophthalmopathy
Haukeland University Hospital 29
Large-scale testing (Phase 3)WithdrawnNCT02393183
What this trial is testing

The Effect of a New Antioxidant Combination (ASTED) on Mild Thyroid Eye Disease (TED)

Who this might be right for
Thyroid Eye Disease
Iran University of Medical Sciences
Large-scale testing (Phase 3)Not Yet RecruitingNCT05049603
What this trial is testing

Clinical Trial to Evaluate the Effects of Atorvastatin on Graves' Orbitopathy (GO): the STAGO-2 Study

Who this might be right for
Graves' Orbitopathy
University of Pisa 102
Next Page